|
BRAND NAME |
GENERIC NAME |
CONDITION |
DOSAGE FORM |
ANTICIPATED LAUNCH |
|
Lucentis® |
Ranibizumab |
Treats macular degeneration and swelling |
Injection and Solution |
2023 |
|
Rayos (1, 2, 5 mg) ® |
Prednisone |
Treats inflammation of the skin, joints, lungs, and other organs |
Tablets |
2023 |
|
Myrbetriq® |
Mirabegron |
Used to treat overactive bladder |
Tablets |
2023 |
|
Humira® |
Adalimumab |
Treats the symptoms of some types of arthritis, Crohns disease, Ankylosis Spondylitis, and plaque psoriasis |
Injection |
2023 |
|
Ibrance® |
Palbociclib |
Used to treat breast cancer |
Cap |
2023 |
|
Nascobal® |
Cyanocobalamin intranasal |
Used to treat some kinds of anemia and prevent low vitamin B12 |
Spray |
2023 |
|
Teflaro® |
Ceftaroline |
Used to treat bacterial infections |
Injection |
2023 |
|
Vyvanse ® |
Lisdexamfetamine Dimesylate |
Used to treat attention deficit problems and binge eating disorder |
Capsules |
2023 |
|
Corlanor ® |
Ivabradine |
Used to treat heart failure |
Tab & Solution |
2023 |
|
Edurant® |
Rilpivirine |
Used to treat HIV |
Tab |
2023 |
|
Livalo ® |
Pitavastatin Calcium |
Lowers bad cholesterol and triglycerides and raises good cholesterol |
Tablets |
2023 |
|
Qtern ® |
Dapagliflozin/Saxagliptin |
Used to lower blood sugar in patients with high blood sugar |
Tablet |
2023 |
|
Victoza® |
Liraglutide |
Used to lower blood sugar in patients with high blood sugar |
Injection |
December 2023 |
|
Complera® |
Emtricitabine, Rilpivirine, Tenofovir |
Used to treat HIV |
Tablets |
January 2024 |
|
Gralise ® |
Gabapentin |
Treats painful nerve diseases |
Tablets |
January 1, 2024 |
|
Omidria® |
Ketorolac 0.3%/Phenylephrine 1% |
Used during eye surgery & to lower eye pain after eye surgery |
Injection |
January 2024 |
|
Ofev® |
Nintedanib |
Used to treat idiopathic pulmonary fibrosis or certain other lung problems |
Capsule |
February 2024 |
|
Dutrebis ® |
Lamivudine; Raltegravir Potassium |
Used to treat HIV-1 infection |
Tablets |
April 04, 2024 |
|
Isentress ® |
Raltegravir Potassium |
Used to treat HIV |
Tablets |
April 4, 2024 |
|
Sprycel (20, 50, 70, 80, 100, & 140mg) ® |
Dasatinib |
Used to treat a type of leukemia |
Tablets |
September 01, 2024 |
|
Stendra ® |
Avanafil |
Used to treat erectile dysfunction |
Tablets |
October 29, 2024 |
|
Brilinta (60 mg) ® |
Ticagrelor |
Used to lower the chance of heart attack, stroke or death |
Tablets |
October 30, 2024 |
|
Nucynta® |
Tapentadol |
Used to ease pain |
Tablets |
October 2024 |
|
Nucynta ER® |
Tapentadol Extended-Release |
Used to ease pain |
Tablets |
October 2024 |
|
Qsymia® |
Phentermine/Topiramate extended-release |
Used to help with weight loss in certain people |
Capsule |
December 2024 |
|
Namzaric® |
Donepezil/Memantine |
Used to treat dementia |
Capsule |
January 2025 |
|
Sancuso® |
Granisetron |
Used to treat upset stomach and throwing up |
Transdermal Patch |
January 22, 2025 |
|
Auryxia® |
Ferric Citrate |
Used to lower high phosphate levels and to treat anemia |
Tablet |
March 20, 2025 |
|
Jentadueto® |
Linagliptin; Metformin Hydrochloride |
Used to lower blood sugar in patients with diabetes |
Tablet |
May 2, 2025 |
|
Jentadueto XR® |
Linagliptin; Metformin Hydrochloride |
Used to lower blood sugar in patients with diabetes |
Tablet |
May 2, 2025 |
|
Tradjenta® |
Linagliptin |
Used to lower blood sugar in patients with diabetes |
Tablet |
May 2, 2025 |
|
Ravicti ® |
Glycerol Phenylbutyrate |
Used to treat urea cycle problems |
Oral Liquid |
July 1, 2025 |
|
Farxiga® |
Dapagliflozin |
Used lower blood sugar in patients with high blood sugar |
Tablets |
October 2025 |
|
Opsumit ® |
Macitentan |
Treats high blood pressure in the lungs |
Tablets |
December 5, 2025 |
|
Xeljanz ® |
Tofacitinib |
Treats some types of arthritis, ulcerative colitis and ankylosing spondylitis |
Tablets |
December 2025 |
|
Xeljanz XR® |
Tofacitinib |
Treats some types of arthritis, ulcerative colitis and ankylosing spondylitis |
Tablets |
December 2025 |
|
Bridion® |
Sugammadex |
Used to reverse the effects of some drugs |
Solution |
January 2026 |
|
Briviact ® |
Brivaracetam |
Used to treat seizures |
Tablets |
February 2026 |
|
*Actual launch dates depend on FDA approvals and may change at any time |
